Clinical significance of REM sleep behavior disorder in Parkinson's disease

Sleep Med. 2013 Feb;14(2):131-5. doi: 10.1016/j.sleep.2012.10.011. Epub 2012 Dec 3.

Abstract

Objective: Rapid eye movement (REM) sleep behavior disorder (RBD) may be a risk factor for dementia development in patients with Parkinson's disease (PD); however, the role of subclinical RBD remains unknown. Patients with PD and clinical RBD, subclinical RBD, or with normal REM sleep were examined in a cross sectional study and a longitudinal follow-up.

Methods: Interviews regarding RBD symptoms and polysomnographies were performed on 82 PD patients divided into RBD subcategories based on the presence/absence of REM sleep without atonia (RWA) and/or RBD symptoms. Descriptive variables were compared and patients were followed-up longitudinally for 21.4±10.8months.

Results: The existence of RBD, but not subclinical RBD, was associated with orthostatic hypotension and levodopa dose equivalents (LDEs) in patients with PD. Kaplan-Myer curves indicated that the occurrence of dementia in the PD group with clinical RBD was significantly faster than in the PD group with normal REM sleep (p=0.013). A Cox hazard regression analysis revealed that development to PD with dementia was only significantly associated with the presence of clinical RBD (hazard ratio: 14.1, p=0.017).

Conclusion: Clinical RBD symptoms, but not subclinical RBD, were associated with the development of dementia in PD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Autonomic Nervous System / physiopathology
  • Blood Pressure / physiology
  • Cross-Sectional Studies
  • Dementia / diagnosis*
  • Dementia / epidemiology
  • Dementia / physiopathology
  • Disability Evaluation
  • Dose-Response Relationship, Drug
  • Female
  • Heart / innervation
  • Humans
  • Hypotension, Orthostatic / diagnosis
  • Hypotension, Orthostatic / epidemiology
  • Hypotension, Orthostatic / physiopathology
  • Kaplan-Meier Estimate
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / epidemiology
  • Parkinson Disease / physiopathology
  • Polysomnography
  • Prognosis
  • Proportional Hazards Models
  • REM Sleep Behavior Disorder / diagnosis*
  • REM Sleep Behavior Disorder / epidemiology
  • REM Sleep Behavior Disorder / physiopathology
  • Sleep Stages / physiology
  • Tilt-Table Test

Substances

  • Antiparkinson Agents
  • Levodopa